Skip to main content
. 2016 Jan 1;10(1):FC09–FC12. doi: 10.7860/JCDR/2016/15621.7099

[Table/Fig-2]:

Age distribution of study group patients (n=100).

Age
(years)
Amikacin group Gentamycin group
n % N %
<20 4 8.0 4 8.0
21-30 7 14.0 8 16.0
31-40 6 12.0 8 16.0
41-50 8 16.0 5 10.0
51-60 7 14.0 6 12.0
61-70 11 22.0 13 26.0
71-80 7 14.0 6 12.0
Total 50 100.0 50 100.0

n = number of patients, % = percentage.